At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
Platelet Rich Plasma +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Platelet-rich Plasma Versus Platelet-rich Plasma Plus Concentrated Insulin-like Growth Factor for Patellar Tendinosis: a Randomized Comparative Trial
In Brief
A clinical study evaluating Platelet Rich Plasma and Platelet Rich Plasma plus IGF for Tendinopathy and 2 related conditions. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to compare two different platelet-rich plasma (PRP) injections for patellar tendinosis. Aim: To perform a randomized, double blinded study comparing the clinical effect of PRP versus PRP + concentrated insulin-like growth factor (IGF) in patients with patellar tendinosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTendinopathy, Patellar Ligament, Platelet-Rich Plasma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartFeb 2020
First PostedApr 2020
Primary CompletionOct 2021
TodayJul 2026
First PostedApr 17, 2020
Enrollment StartFeb 25, 2020
Primary CompletionOct 16, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.2 years ago
Interventions
Platelet Rich Plasmadevice
Platelet rich plasma injection into patellar tendon
Platelet Rich Plasma plus IGFdevice
Platelet rich plasma plus IGF injection into patellar tendon